← back to search

Benno Schwikowski

Institut Pasteur · FR
Area of research
Molecular Biology · Spectroscopy
Research interest
Research interests include Bioinformatics and Genomic Networks, Genomics and Phylogenetic Studies, Gene expression and cancer classification, and Metabolomics and Mass Spectrometry Studies.
h-index
38
citations
67,704
works
128
NIH funding
primary concept
Biology
email

Recent publications

Single-Cell Transcriptomic Signatures Enable Stratified Combination Therapy for Platinum-Resistant Ovarian Cancer
2026cited by 0position: contributordoi
Identification of Monotonically Classifying Pairs of Genes for Ordinal Disease Outcomes
2025cited by 1position: contributordoi
Smoking changes adaptive immunity with persistent effects
Nature 2024cited by 169position: middledoi
Consensus Clustering for Robust Bioinformatics Analysis
2024cited by 1position: contributordoi
Identification of new candidate drugs for primary Sjögren's syndrome using a drug repurposing transcriptomic approach.
2023cited by 7position: contributordoi
Towards the Genome-scale Discovery of Bivariate Monotonic Classifiers
2023cited by 1position: contributordoi
Capturing the dynamics of microbiomes using individual-specific networks
2023cited by 0position: contributordoi
Author Correction: A shared disease-associated oligodendrocyte signature among multiple CNS pathologies.
2023cited by 0position: contributordoi
A shared disease-associated oligodendrocyte signature among multiple CNS pathologies.
2022cited by 189position: contributordoi
The immune factors driving DNA methylation variation in human blood
Nature Communications 2022cited by 77position: middledoi
An overview of machine learning methods for monotherapy drug response prediction.
2022cited by 36position: contributordoi
Deciphering the state of immune silence in fatal COVID-19 patients.
2021cited by 130position: contributordoi
Differential levels of IFNα subtypes in autoimmunity and viral infection
2021cited by 0position: contributordoi
LGP2 binds to PACT to regulate RIG-I- and MDA5-mediated antiviral responses.
2019cited by 54position: contributordoi
Parallel derivation of isogenic human primed and naive induced pluripotent stem cells
Nature Communications 2018cited by 137position: middledoi
From the exposome to mechanistic understanding of chemical-induced adverse effects
Environment International 2016cited by 211position: middledoi
Condition-Dependent Transcriptome Reveals High-Level Regulatory Architecture in <i>Bacillus subtilis</i>
Science 2012cited by 937position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 12 papers (2019–2026)Behnam Yousefi · Institut Pasteur3 papers (2022–2024)Ido Amit · Melodea (Israel)3 papers (2021–2023)Hongjun Fu · State Key Laboratory of Applied Organic Chemistry2 papers (2022–2023)Martin S. Krejca · Ecole Polytechnique, Institut Polytechnique de Paris2 papers (2023–2025)Qin Ma · The Ohio State University2 papers (2022–2023)Carola Doerr · Sorbonne Université2 papers (2023–2025)Bernd Bodenmiller · Life Science Zurich2 papers (2022–2023) · 2 papers (2025–2026)Océane Fourquet · Institut Pasteur2 papers (2023–2025)Michal Schwartz · Check Point (Israel)2 papers (2022–2023)Sampsa Hautaniemi · University of Helsinki2 papers (2025–2026)Stanislas Pol · Groupe Hospitalier Cochin - Port-Royal, Hôtel-Dieu, Broca - La Collégiale1 papers (2021–2021)Tsutomu Takeuchi · Keio University1 papers (2023–2023)Tracy A Briggs · Manchester Academic Health Science Centre1 papers (2021–2021)Guillaume Beauclair · Centre National de la Recherche Scientifique1 papers (2019–2019)Nolwenn Jouvenet · Department of Virology1 papers (2019–2019)Jun Dai · Soochow University1 papers (2026–2026)Raul Y. Sanchez-David · Imperial College London1 papers (2019–2019)Flore Rozenberg · Institut Pierre Louis d‘Épidémiologie et de Santé Publique1 papers (2021–2021)